- $31.00m
- -$7.81m
- $1.73m
- 77
- 11
- 83
- 58
2019 December 31st | 2020 December 31st | R2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.9 | 31.2 | 1.45 | 1.66 | 1.73 |
Cost of Revenue | |||||
Gross Profit | 12.5 | 10.9 | 0.735 | 0.818 | 0.932 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 28.5 | 29.7 | 4.97 | 3.73 | 3.03 |
Operating Profit | 3.44 | 1.42 | -3.52 | -2.07 | -1.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3.91 | 1.3 | 16 | -6.41 | 0.646 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.02 | 0.968 | 12.6 | -4.88 | 0.345 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 7.02 | 0.968 | 14.6 | -2.99 | 0.269 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.02 | 0.968 | 14.6 | -2.99 | 0.269 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.705 | 0.186 | 2.35 | -0.914 | 0.055 |
Dividends per Share |